Lanzamiento Enero 2027

Revisión sistemática2025Financiación no declarada

Evidence-based consensus on the clinical application of photobiomodulation

Maghfour J, Mineroff J, Ozog DM, Jagdeo J, Lim HW, Kohli I, Anderson R, Kelly KM, Mamalis A, Munavalli G, Cleber F, Siegel D, Geneva I, Weiss R, Morita A, Juanita A, Goldman MP, Arany PR, Sliney D, Ibrahimi OA, Chopp M, Esmat S, Tuner J

Journal of the American Academy of Dermatology · 18 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Revisión sistemática (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2025-04-17 · J Am Acad Dermatol · vol. 93 · número 2 · págs. 429–443
Editorial
Elsevier BV
Citado
38 citas · más que el 100% de estudios similares · 20.3× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
178 trabajos
Acceso
Acceso abierto (copia en repositorio) · CC-BY
Áreas de investigación
Laser Applications in Dentistry and Medicine · Biofield Effects and Biophysics · Dermatologic Treatments and Research
Palabras clave
low-level laser therapy, peripheral neuropathy, androgenetic alopecia, diabetic foot ulcer, pressure ulcers, acute radiation dermatitis, treatment safety, DNA damage, pain management
MeSH
humans, skin diseases, alopecia, evidence-based medicine, delphi technique, low-level light therapy

23 autores

  • Jalal Maghfour🇺🇸Henry Ford Health; Henry Ford Hospital
  • Jessica Mineroff🇺🇸SUNY Downstate Health Sciences University
  • David Ozog🇺🇸 · autor de correspondenciaHenry Ford Health; Henry Ford Hospital; Henry Ford Health + Michigan State University Health Sciences; Michigan State University
  • Jared R. Jagdeo🇺🇸SUNY Downstate Health Sciences University
  • Henry W. Lim🇺🇸Henry Ford Health; Henry Ford Hospital; Michigan State University
  • Indermeet Kohli🇺🇸Henry Ford Health; Henry Ford Hospital
  • R. Rox Anderson🇺🇸Massachusetts General Hospital
  • Kristen M. Kelly🇺🇸University of California, Irvine
  • Andrew Mamalis🇺🇸Kaiser Permanente; Kaiser Permanente Modesto Medical Center and Medical Offices
  • Gilly S. Munavalli🇺🇸Dermatology, Laser & Vein Specialists of the Carolinas
  • Cleber Ferraresi🇧🇷Universidade Federal de São Carlos
  • Daniel Siegel🇺🇸SUNY Downstate Health Sciences University
  • Ivayla I. Geneva🇺🇸Crouse Hospital
  • Robert A. Weiss🇺🇸Maryland Dermatology Laser Skin and Vein Institute; University of Maryland, College Park
  • Akimich Morita🇯🇵Nagoya City University
  • Anders Juanita🇺🇸Uniformed Services University of the Health Sciences
  • Mitchel P. Goldman🇺🇸University of California San Diego
  • Paraveen R. Arany🇺🇸University at Buffalo, State University of New York
  • David H. Sliney🇺🇸🇫🇷Johns Hopkins University; Johns Hopkins Medicine; Physique pour la médecine Paris
  • Omar A. Ibrahimi🇺🇸Connecticut Skin Institute
  • Michael Chopp🇺🇸Henry Ford Health; Henry Ford Hospital
  • Samia M. Esmat🇪🇬Cairo University
  • Jan Tunér🇸🇪Karolinska Institutet

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

There is a lack of evidence-based consensus to assist clinicians in using photobiomodulation (PBM).

Objective

To create a consensus on the safe and effective use of PBM.

Methods

A systematic literature review of Embase and MEDLINE was conducted in June 2022 to identify publications reporting research on PBM. An international multidisciplinary panel was convened to draft recommendations informed by the systematic search; they were refined through 2 rounds of Delphi survey, 2 consensus meetings, and iterative review by all panelists until unanimous consensus was achieved.

Results

A multidisciplinary panel of experts (n = 21) was assembled based on publication history. The key findings that informed the consensus developed by the expert panel were as follows: PBM is a safe treatment modality for adult patients and red light PBM does not induce DNA damage. PBM is an effective treatment option for peripheral neuropathy, androgenic alopecia, wound ulcers due to multiple etiologies, decubitus ulcers, pain attributed to diabetic foot ulcers, and acute radiation dermatitis.

Conclusion

The systematic literature search and structured Delphi consensus approach culminated in an evidence-based clinical practice guideline for safe and effective use of PBM in medical and aesthetic applications. Future research will further bolster our understanding of this evolving noninvasive technique.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.